Treatment and management of myelofibrosis in the era of JAK inhibitors
Clodagh Keohane, Deepti H Radia, Claire N HarrisonDepartment of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UKAbstract: Myelofibrosis (MF) can present as a primary disorder or evolve from polycythemia vera (PV) or essential thrombocythemia (ET) to post-PV MF or po...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-08-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/treatment-and-management-of-myelofibrosis-in-the-era-of-jak-inhibitors-a14104 |